Related Experiment Video
Updated: Dec 29, 2025

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
Murine osteoclastogenesis suppression using conditioned media produced by melanoma or activated and non-activated
Nicole C Mambelli-Lisboa1,2, Eduardo O Frare1,2, Adriana da Costa-Neves1,2
1Laboratory of Genetics, Butantan Institute, São Paulo, Brazil.
Abstract:
Conditioned medium (CM) (cell secretome) is a cocktail of growth factors, cytokines, and other soluble mediators secreted by cells into a culture medium. These growth factors are fundamental in many cellular processes such as cell growth, differentiation, and others and the composition of these factors is individual for each cell type. Osteoclasts are large multinucleated cells that are responsible for bone resorption. Immune and cancer cells are known to produce different growth factors, which are able to induce or inhibit osteoclast differentiation. Herein, we evaluated the effect of CM obtained from the supernatant of activated and non-activated Jukart-E6 cells, as well as from one murine (B16-F10) and one human melanoma cell line (SK-MEL-28). To induce osteoclast differentiation, murine bone marrow mononuclear cells were cultured in the presence and absence of differentiation factors (DF), such as macrophage colony-stimulating factor, prostaglandin E2, receptor activator of nuclear factor-κB ligand, and CM. We measured the concentration of interleukin 6, tumor necrosis factor-α and interferon γ (IFN-γ) in CM that can inhibit or induce osteoclastogenesis. Our study demonstrated that CM obtained from each cell line suppresses or inhibits osteoclasts formation at early and intermediate stages of differentiation in the absence or presence of DF. CM obtained from activated Jurkat-E6 cells demonstrates a stronger effect when compared with CM from naïve Jurkat-E6 cells or human and murine melanoma cells. Moreover, CM obtained from activated Jurkat-E6 cells shows higher secretion of IFN-γ, which is an inhibitor of osteoclastogenesis, in comparison with CM obtained from the three other cell lines. On the other hand, CM derived from B16-F10 cells showed a smaller inhibitory effect when compared with CM derived from the other cells.
Insights
Conditioned medium (CM) from activated immune cells, particularly Jurkat-E6 cells, significantly inhibits osteoclast formation. This effect is linked to higher levels of interferon gamma (IFN-γ), a key inhibitor of osteoclastogenesis.
Area of Science:
- Cell Biology
- Immunology
- Bone Biology
Background:
- Conditioned medium (CM) contains soluble mediators influencing cellular processes.
- Osteoclasts are crucial for bone resorption, and their differentiation can be modulated by various cell types.
- Immune and cancer cells secrete factors that impact osteoclast differentiation.
Purpose of the Study:
- To investigate the effect of CM from different cell lines on osteoclast differentiation.
- To compare the inhibitory potential of CM from activated and non-activated Jurkat-E6 cells, and from melanoma cell lines.
- To identify specific factors within CM, such as IFN-γ, that mediate osteoclastogenesis inhibition.
Main Methods:
- Murine bone marrow mononuclear cells were cultured to induce osteoclast differentiation.
- CM from activated/non-activated Jurkat-E6, B16-F10 (murine melanoma), and SK-MEL-28 (human melanoma) cells were applied.
- Concentrations of IL-6, TNF-α, and IFN-γ in CM were measured.
- Osteoclast formation was assessed at early and intermediate differentiation stages.
Main Results:
- CM from all tested cell lines suppressed osteoclast formation.
- CM from activated Jurkat-E6 cells exhibited a stronger inhibitory effect than CM from naive Jurkat-E6 or melanoma cells.
- Activated Jurkat-E6 CM showed significantly higher IFN-γ secretion compared to other CMs.
- B16-F10 derived CM had a comparatively weaker inhibitory effect.
Conclusions:
- CM, especially from activated immune cells like Jurkat-E6, effectively inhibits osteoclast differentiation.
- IFN-γ is a key mediator in the observed inhibition of osteoclastogenesis by activated Jurkat-E6 CM.
- The study highlights the potential of specific cell secretomes in modulating bone resorption processes.

